繁體
简体中文
繁體中文

American Century Securitized Credit ETF ASEC 深 滬

已收盤 11-06 16:00:00 美东时间

49.255

+0.050

+0.10%

华盛通華盛通
立即下載
  • 最 高49.255
  • 今 開49.20
  • 成交量 7股
  • 最 低 49.255
  • 昨 收 49.205
  • 總市值 1970.20万
  • 52周最高 49.5329
  • 市盈率 靜 --
  • 換手率 0.00%
  • 52周最低 48.7301
  • 委 比 0.00%
  • 總股本 40.00万
  • 歷史最高 49.5329
  • 量 比 0
  • 振 幅 0.00%
  • 歷史最低 48.7301
  • 每 手 1
  • 風險率 0.16%

個股概要

財務分析

公司資料

相關新聞

分紅派息

  • 分時圖
  • 日k
  • 周k
  • 月k

相關新聞

更多
  • Satellos to Host Investor Call to Provide an Update on Clinical and Regulatory Strategy for the BASECAMP Phase 2 Pediatric Study

    Satellos Bioscience Inc. will host a conference call and audio webcast on Nov. 6, 2026, at 8:00 a.m. ET to discuss updates on the clinical and regulatory strategy for its Phase 2 pediatric study, BASECAMP, for Duchenne muscular dystrophy (DMD). The call will feature remarks from Satellos' CEO Frank Gleeson and Chief Medical Officer Wildon Farwell, M.D. A live webcast with accompanying slides will be available on the company's website, with a repl...

    11-05 21:32

  • Satellos Establishes Scientific Advisory Board to Explore the Biology of Regeneration in Aging and Neuroscience

    Satellos Bioscience Inc. has formed a Scientific Advisory Board (SAB) with leading experts in stem cell biology, regenerative medicine, neuroscience, and small molecule chemistry to guide its research on regeneration, aging, and neurodegenerative biology. The SAB will help explore how cellular processes influence aging, neurodegeneration, and muscle diseases, expanding Satellos' understanding of regenerative biology. The company is currently deve...

    10-27 11:00

  • Satellos to Participate in Upcoming Investor Conferences

    Satellos Bioscience Inc. announced its participation in two upcoming investor conferences in November 2026: the Guggenheim 3rd Annual Healthcare Innovation Conference in Boston on November 9 and the Jefferies Global Healthcare Conference in London on November 18-19. The company will also host one-on-one investor meetings at both events. Satellos, focused on developing treatments for degenerative muscle diseases, is advancing forazapadin, an AAK1 ...

    10-21 11:00

  • AMERICAN CENTURY LAUNCHES SECURITIZED CREDIT ETF

    KANSAS CITY, Mo., May 28, 2026 /PRNewswire/ -- American Century Investments, a $330 billion global asset manager*, expands its exchange traded fund (ETF) platform with the launch of American...

    05-28 22:37